BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 1714)

  • 1. The central action of drugs influencing beta-adrenergic receptor. part V. The interaction of drugs affecting beta-adrenergic receptor in motility test.
    Ksiaz A; Kleinrok Z
    Pol J Pharmacol Pharm; 1975; 27(6):595-601. PubMed ID: 1714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The central action of drugs affecting beta-adrenergic receptor. IV. The influence of intraventricularly administered drugs affecting beta-adrenergic receptor on blood pressure in rats.
    Kleinrok Z; Ksiazek A
    Pol J Pharmacol Pharm; 1975; 27(2):177-82. PubMed ID: 239397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of cholecystokinin (CCK-33) and its C-terminal fragments: CCK-8 and CCK-4 with alpha- and beta-adrenoceptor agonists and antagonists in the cardiovascular system of rats. Part A.
    Wiśniewska RJ
    Pol J Pharmacol; 1998; 50(3):203-12. PubMed ID: 9861628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of beta-adrenergic receptor blocking agents on hypertensive action of noradrenaline injected into the lateral ventricle of rat brain.
    Kleinrok Z; Ksiazek A
    Pol J Pharmacol Pharm; 1977; 29(4):405-9. PubMed ID: 20610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Central adrenergic receptors and the regulation of hunger and thirst.
    Leibowitz SF
    Res Publ Assoc Res Nerv Ment Dis; 1972; 50():327-58. PubMed ID: 4403655
    [No Abstract]   [Full Text] [Related]  

  • 6. Central regulation of blood eosinophilia by the beta-adrenergic system in rats.
    Szczeklik A; Podolec Z
    Int Arch Allergy Appl Immunol; 1976; 50(3):328-40. PubMed ID: 2558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of cholecystokinin (CCK-33) and its C-terminal fragments: CCK-8 and CCK-4 with alpha- and beta-adrenoceptor agonists and antagonists in the cardiovascular system of diabetic rats. Part B.
    Wiśniewska RJ
    Pol J Pharmacol; 1998; 50(3):213-23. PubMed ID: 9861629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The central action of drugs affecting beta-adrenergic receptor. III. The influence on oxygen consumption in rat's hypothalamus in vitro.
    Kleinrok Z; Ksiazek A; Goworek J
    Pol J Pharmacol Pharm; 1974; 26(5):493-7. PubMed ID: 4427809
    [No Abstract]   [Full Text] [Related]  

  • 9. Catecholaminergic regulation of the hypothalamic-pituitary-adrenocortical activity.
    Bugajski J; Turoń M; Gadek-Michalska A; Borycz JA
    J Physiol Pharmacol; 1991 Mar; 42(1):93-103. PubMed ID: 1681965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of beta-receptor stimulation on the activity of the inhibitor of cAMP-dependent protein kinase.
    Szmigielski A
    Acta Physiol Pol; 1981; 32(5):501-6. PubMed ID: 6121459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Central action of drugs affecting beta-adrenergic receptor. II. The central action of intraventricularly applicated propranolol in rats.
    Ksiazek A; Kleinrok Z
    Pol J Pharmacol Pharm; 1974; 26(3):297-304. PubMed ID: 4859243
    [No Abstract]   [Full Text] [Related]  

  • 12. Adrenergic receptors in the nucleus accumbens shell differentially modulate dopamine and acetylcholine receptor-mediated turning behaviour.
    Ikeda H; Moribe S; Sato M; Kotani A; Koshikawa N; Cools AR
    Eur J Pharmacol; 2007 Jan; 554(2-3):175-82. PubMed ID: 17113067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Permanent effects of postnatal administration of beta-adrenergic ligands on the volume of sexually dimorphic nucleus of the preoptic area (SDN-POA) in rats.
    Izdebska-Straszak G; Gubala E; Jedrzejowska-Szypulka H; Klencki M; Wiczkowski A; Jarzab B
    Neuro Endocrinol Lett; 2006; 27(1-2):105-13. PubMed ID: 16648786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of the adrenergic drugs on the electrical responses of the rabbit isolated heart atrium.
    Smejkal V; Mironneau J; Ojeda C; Gargouil YM
    Physiol Bohemoslov; 1970; 19(1):19-22. PubMed ID: 4394505
    [No Abstract]   [Full Text] [Related]  

  • 15. Differential inhibition of lipolysis in human adipose tissue by adrenergic beta receptor blocking drugs.
    Frisk-Holmberg M; Ostman J
    J Pharmacol Exp Ther; 1977 Mar; 200(3):598-605. PubMed ID: 15099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of beta-adrenoceptors on the behaviour induced by the neuropeptide glutamic acid isoleucine amide.
    Sánchez-Borzone ME; Attademo A; Baiardi G; Celis ME
    Eur J Pharmacol; 2007 Jul; 568(1-3):186-91. PubMed ID: 17537427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Changes in the level of adenylic nucleotides and oxidation enzymes in the myocardium during the action of drugs on the adrenoreceptors].
    Chekman IS
    Biull Eksp Biol Med; 1973 Jul; 76(7):64-6. PubMed ID: 4149446
    [No Abstract]   [Full Text] [Related]  

  • 18. Catecholamines stimulate steroid secretion of dispersed fowl adrenocortical cells, acting through the beta-receptor subtype.
    Mazzocchi G; Gottardo G; Nussdorfer GG
    Horm Metab Res; 1997 Apr; 29(4):190-2. PubMed ID: 9178030
    [No Abstract]   [Full Text] [Related]  

  • 19. The influence of adrenergic and some other cardioactive drugs on electric activity of the isolated frog atrium.
    Smejkal V; Rougier O; Garnier D
    Physiol Bohemoslov; 1970; 19(1):23-5. PubMed ID: 4394506
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of beta-adrenergic blocking agents on the spontaneous motility of mice.
    Fabian HE; Izquierdo JA
    Arzneimittelforschung; 1972 Aug; 22(8):1375-6. PubMed ID: 4404659
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.